Why GLP-1 drugs and menopause could create a perfect storm for bone loss Bone loss can lead to osteoporosis, which causes bones to become porous, weaker and brittle, making them more likely to break, often in the hips, spine and wrists
PT-141 used outside the FDA-approved Vyleesi indication is off-label and not supported by Phase 3 evidence in those populations
Elderly Patients Older adults may be more sensitive to side effects, particularly: Dehydration from gastrointestinal effects Falls risk from dizziness or low blood sugar Drug interactions with multiple medications Need for slower dose escalation Women of Childbearing Age Important considerations include: Both medications should be stopped 2 months before planned pregnancy Weight loss may improve fertility in some women Reliable contraception recommended during treatment Not recommended during breastfeeding The Future of Weight Loss Medications The field of obesity medicine continues to evolve rapidly
Metformin Metformin, a biguanide, has been used as the first-line treatment for T2DM for several decades
A diferencia de otros activos, la L-Carnitina funciona como la llave de paso para la eliminacin real de la grasa
extracted from C
